More about Sun Pharmaceutical Industries Limited
Fundamentals for Sun Pharmaceutical Industries Limited
Regulatory Filings for Sun Pharmaceutical Industries Limited
From Cost Center to Strategic Core: The Top 10 Trends Transforming Finance in 2026
CFOs Seize the Tech Purse Strings: How 2026 Budgets Are Fueling the AI Transformation
From Agentic AI to Tokenized Assets: The Fintech Trends Reshaping Financial Services
Forex Focus: How a Weakening Indian Rupee Could Reshape Markets in Q1 2026
Technicals for Sun Pharmaceutical Industries Limited
Price Summary
Sun Pharmaceutical Industries Limited's stock saw a 2.37% boost, showcasing an impressive market day.2026-03-02, saw SUNPHARMA's stock open at 1712.0, hit a peak of 1759.9, fall to a low of 1712.0, and close up 2.37% at 1752.5, with 3919016 shares changing hands.
During the 52-week span, the stock hit a high of 1841.6 and a low of 1563.3.
Analysts' predictions indicate that SUNPHARMA's future price will be between 1575.0 and 2450.0, with a mean price expectation of approximately 1965.2894.
Technicals
Support and Resistance: At 1752.5, the price is supported at 1745.9 and faces resistance at 1777.4. This range suggests that the price for SUNPHARMA might stay between these levels, with 1745.9 acting as a floor and 1777.4 as a ceiling.Aroon: The current state of the AROON is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
Bol. Bands: The BOLL BANDS is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
Parabolic SAR: The PSAR for SUNPHARMA maintains its bullish outlook, setting a strong support level that could underpin further gains. This suggests that the market is likely to continue its upward trajectory, with the established support providing a safety net for ongoing bullish momentum.
Stochastic: The current state of the STOCHASTIC is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
Tripple Moving Agerage: The Tripple MOVING AVG is in a neutral stance for SUNPHARMA, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
Before diving into the technical aspects of a company, such as stock price charts or volume trends, it's important to understand its fundamentals. These fundamentals include financial stability, growth potential, and strategic positioning. Additionally, knowing the broader industry landscape, including competitive pressures and regulatory factors, offers deeper insights. When this fundamental analysis is combined with technical indicators, it leads to more informed, accurate evaluations of the company's overall performance.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
Understanding Divergent House Price Movements Worldwide
The 2026 Tariff Tipping Point: When Trade Policy Reaches the Consumer
From Caracas to Commodities: The Market Impact of U.S.–China Friction